• 

  Complete Genomics Adds Eurofins Clinical Enterprise, LLC to its Sequencing Service Provider Program

  Dec 17, 2024Mar 10, 2025
• 

  ASHG 2024: Advancing Human Genetics Through Multi-Omics Innovation

  Nov 21, 2024Feb 10, 2026
• 

  Complete Genomics announces mpox virus amplicon sequencing panel at AMP

  Nov 20, 2024Feb 10, 2026
• 

  Complete Genomics Announces Spatial Omics Distributor Agreement, Debuts Spatial Xcellerator Grant Program at SITC 2024

  Nov 5, 2024Mar 10, 2025
• 

  Complete Genomics Highlights Innovation with Expanded Multi-Omics and Spatial Transcriptomics Applications at ASHG 2024

  Nov 4, 2024Mar 10, 2025
• 

  Complete Genomics integrates NVIDIA Parabricks to offer researchers faster, more cost-effective and accurate genomic sequencing analysis

  Oct 29, 2024Mar 12, 2025
• 

  What is Stereo-seq? Revolutionizing Spatial Transcriptomics with Unmatched Resolution and Scale

  Sep 30, 2024Feb 10, 2026
• 

  AdvancedDx Biological Laboratories USA Inc. and Complete Genomics LLC to co-market NGS microbiology solution in the U.S.

  Sep 23, 2024Mar 12, 2025
• 

  What is Spatial Transcriptomics? Transforming Gene Expression Analysis

  Sep 19, 2024Feb 10, 2026
• 

  The Race to Affordable Next-Generation Sequencing Costs: From the $1,000 Genome to the Sub-$100 Genome

  Sep 16, 2024Feb 10, 2026
• 

  Complete Genomics opens U.S. supply chain to genomic sequencing customers through a new manufacturing facility at its San Jose, Calif. headquarters 

  May 23, 2024Mar 10, 2025
• 

  Complete Genomics expands to East Coast with new Customer Experience Center in Greater Boston’s Biotech Hub 

  May 21, 2024Mar 10, 2025